Member Info for SPOT

Predictions on finish for today...the winner gets to post "I told you so" my shot 41.5 ...and since its my game, I set the rules and therefore I'm allowed another guess around 12.25 today...Happy New Year All

Herclues has put 20 million on the table for mtfb, 15 of which was drawn down straight away and 5 kept back till 2018....just paperwork to be done for now as we seek FDA approval ....if Herclues is happy forking out those sums, them it adds a little confidence to what's happening atm.

Can we hold 40 today ? Or are we just having a breather ?slowly ,slowly as they say, if we don't do it today, next year should see some excitement ...

Is only posting a week and here to stir. 41 been nibbled at now.

Of the woodwork. As soon as we get a bit of overdue momentum.....someone starts to mention funds needed. Go away .Your call lads, but I say don't entertaine him.

You guys don't believe this nonsense your posting, any guesses when the next fund raising will be ?

Where to next ?

Should see the back of 40 today...gla

I see we have had a little nudge in the right direction over on Nasdaq, lets hope the start of the New Year brings us a little upward movement.. its well over due.gla

With a bit of luck, we'll see the back of it tomorrow.Gla

Past 40 today would be nice...

Yes, we was...lol Hoping they're just holding them for the rally in the New Year.gla

Keep dreaming....lol

Good luck for the New Year.

We didn't have a bigger jump this morning, still a bit of time left for a late surge.Gla

Don't let them get you down....lol

Judgements come from lessons learnt ....especially from past mistakes. I shoot this company down at every chance I get, so take my advice and keep clear .......but its your money at the end of the day..good luck whatever you do

2% knocked of the value of the company....lol

It will be interesting to see how they play this with two substantial bits of news to come and two trading weeks left.Gla

Don't we have news due anytime now re RPL554 trial on COPD and RPL554 trial on CF, both are due final quarter of 2017.